Global Asthma Drugs Market Drug Class (Combination therapies (ICS/LABAs), Long-acting beta agonists (LABAs), Short-acting beta agonists (SABAs), Inhaled corticosteroids (ICS), Oral and intravenous corticosteroids, Leukotriene modifiers, Other drug classes) Product ( Inhalers, Dry Powder, Metered Dose, Soft Mist, Nebulizers) Route of Administration (Oral, Inhaled, Others) By Distribution (Channel, Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, E-Commerce) By End-use, Hospitals & clinics, Ambulatory surgical centers, Homecare settings) Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Oct 2024
- Report ID: 130279
- Number of Pages: 247
- Format:
-
keyboard_arrow_up
-
-
- Teva Pharmaceutical Industries Ltd.
- GSK plc
- Merck & Co., Inc.
- F. Hoffmann-La Roche Ltd
- AstraZeneca
- Boehringer Ingelheim International GmbH
- Sanofi.
- Koninklijke Philips N.V.
- BD
- Covis Pharma
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible



